Overview

A Study to Evaluate the Bioavailability of Fedratinib When Administered in Different Ways to Healthy Adult Participants

Status:
Not yet recruiting

Trial end date:
2021-12-29

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the relative bioavailability of fedratinib in healthy adult participants.

Phase:

Phase 1

Details

Lead Sponsor:

Bristol-Myers Squibb